[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356379-105":59,"doc-detail-356379-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","palmitic-acid-triggered-b7h3-palmitoylation-promotes-immune-escape","Palmitic acid-triggered B7H3 palmitoylation promotes immune escape","","Colorectal cancer often resists immune checkpoint blockade in microsatellite-stable (MSS) tumors, driving the search for alternative immune targets. The study shows that palmitic acid (PA) enhances B7H3 palmitoylation at cysteine 496 via ZDHHC24, blocking binding to SQSTM1/p62 to limit autophagic degradation and stabilize B7H3. This suppresses CD8+ T cell antitumor activity. Disrupting the pathway, including Zdhhc24 deletion in a mouse model, boosts CD8+ responses, and a ZDHHC24–B7H3 blocking peptide synergizes with PD-1 inhibition.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/palmitic-acid-triggered-b7h3-palmitoylation-promotes-immune-escape/356379/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/palmitic-acid-triggered-b7h3-palmitoylation-promotes-immune-escape/356379.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are immune checkpoint inhibitors less effective for most colorectal cancer patients?","Question",{"text":112,"@type":113},"Most responses are limited in microsatellite-stable (MSS) colorectal cancers, where immune checkpoint blockade targeting PD-1/PD-L1 tends to show poor success compared with MSI-H tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does palmitic acid influence B7H3 levels in MSS colorectal cancer?",{"text":117,"@type":113},"Palmitic acid promotes B7H3 palmitoylation at cysteine 496 through ZDHHC24, which prevents B7H3 from binding SQSTM1/p62, reduces autophagic degradation, and stabilizes B7H3 protein expression.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the effects of disrupting ZDHHC24–B7H3 palmitoylation?",{"text":121,"@type":113},"Mutating cysteine 496 or deleting Zdhhc24 in a colitis-associated colorectal cancer mouse model enhances CD8+ T cell responses and counteracts immune escape. A cell-penetrant peptide blocking ZDHHC24–B7H3 interaction further boosts antitumor immunity and synergizes with PD-1 blockade.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356379,1790180019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article [https://doi.org/10.1038/s41467-026-68525-x](https://doi.org/10.1038/s41467-026-68525-x)  \nPalmitic acid-triggered B7H3 palmitoylation promotes immune escape  \nReceived: 5 March 2025  \n\n| Accepted: 8 January 2026 |\n| --- |\n| |\n| Check for updates |\n\nZejun Rao1, Changsheng Huang 1, Qi Wu1, Mao Li 1, Anyi Liu1, Tong Zhu1, Wangshuo Yang1, Lanlan Yin1, Shengyu Zhu 1, Xiaowei She1, Chengxin Yu1, Lang Liu1, Pengcheng Li1, Yucong Bai1, Dongjing Zhang1, Tianci Xie1, Xiang Liu1, Lu Liu1, Feng Xu1, Guihua Wang 1,2, Junbo Hu 1  & Xuelai Luo1   \nColorectal cancer responds poorly to immune checkpoint blockade in most patients with microsatellite-stable (MSS) tumors, highlighting the need for alternative targets. B7H3 (CD276) is an immune checkpoint protein that is frequently overexpressed in tumors, but how it is maintained at high protein levels is unclear. Here we show that palmitic acid (PA) promotes B7H3 palmitoylation by the palmitoyltransferase ZDHHC24 at cysteine 496. This modiﬁcation prevents B7H3 from binding to sequestosome 1 (SQSTM1, also called p62), limiting autophagic degradation and stabilizing B7H3, which suppresses CD8+ T cell antitumor activity. Disrupting this pathway by mutating cysteine 496, or by deleting Zdhhc24 in a colitis-associated colorectal cancer (CAC) mouse model, enhances CD8+ T cell responses. We also develop a cellpenetrant peptide that blocks the ZDHHC24–B7H3 interaction, boosts antitumor immunity, and synergizes with blockade of programmed cell death protein 1 (PD-1). These ﬁndings identify B7H3 palmitoylation as a targetable metabolic–immune node for colorectal cancer immunotherapy.  \nColorectal cancer is the third most common cancer worldwide1. Traditionally, surgery has been the primary treatment, but recent advances suggest that immunotherapy may offer durable and potentially curative outcomes2. Immune checkpoints, such as programmed death- 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic Tlymphocyte–associated antigen 4 (CTLA-4), play crucial roles in maintaining self-tolerance and regulating antitumor immunity3–5. These checkpoint pathways involve receptor–ligand interactions that deliver co-inhibitory signals to T cells, thereby suppressing their activation and effector function. Immune check point inhibitors (ICIs) targeting PD-1/PD-L1 are effective primarily in microsatellite instabilityhigh (MSI-H) colorectal cancers, which constitute only about 15% of cases6–9. In contrast, these treatments show limited success in the majority of colorectal cancers that are microsatellite-stable (MSS)10,11. Therefore, it is imperative to conduct an intensive search for alternative immune checkpoints to apply in the treatment of MSS tumors.  \nThe B7 family, comprising a group of structurally related transmembrane proteins, including B7-1, B7-2, B7-H1 (also known as PD-L1), B7-H3, and others, interacts with CD28 family receptors to either stimulate or suppress immune response12–14. B7H3 (CD276) has recently emerged as a compelling immunotherapy target due to its role in suppressing cytotoxic T cell and natural killer cell activity15–18. B7H3 is highly expressed in various malignancies, and its elevated expression is associated with poor prognosis and adverse clinical outcomes19–22. Although B7H3 mRNA is widely detectable across various tissues and cell types, protein expression is comparatively limited, suggesting that posttranscriptional mechanisms tightly regulate its abundance23. Posttranslational modiﬁcations (PTMs) of B7H3 remain underexplored, yet they are likely to play important roles in modulating its function in cancer. While phosphorylation and ubiquitination sites have been predicted, N-glycosylation plays a pivotal role in stabilizing B7H3 and ensuring its stable expression on the plasma membrane,  \n1GI Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China. 2State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infecti","cbCaiu77XyDHxOR0","https://ap.wps.com/l/cbCaiu77XyDHxOR0","pdf",4867584,24,"English","# Background\n## Immune checkpoint blockade and MSS limitations\n## B7 family and B7H3 as a target\n# Mechanistic findings\n## ZDHHC24-mediated palmitoylation of B7H3\n## Impact on SQSTM1/p62 binding and autophagy\n## Consequences for CD8+ T cell activity\n# Therapeutic strategies\n## Disrupting the B7H3 palmitoylation pathway\n## ZDHHC24–B7H3 blocking peptide and PD-1 synergy\n# Implications\n## Targetable metabolic–immune node in colorectal immunotherapy","[{\"question\":\"Why are immune checkpoint inhibitors less effective for most colorectal cancer patients?\",\"answer\":\"Most responses are limited in microsatellite-stable (MSS) colorectal cancers, where immune checkpoint blockade targeting PD-1/PD-L1 tends to show poor success compared with MSI-H tumors.\"},{\"question\":\"How does palmitic acid influence B7H3 levels in MSS colorectal cancer?\",\"answer\":\"Palmitic acid promotes B7H3 palmitoylation at cysteine 496 through ZDHHC24, which prevents B7H3 from binding SQSTM1/p62, reduces autophagic degradation, and stabilizes B7H3 protein expression.\"},{\"question\":\"What are the effects of disrupting ZDHHC24–B7H3 palmitoylation?\",\"answer\":\"Mutating cysteine 496 or deleting Zdhhc24 in a colitis-associated colorectal cancer mouse model enhances CD8+ T cell responses and counteracts immune escape. A cell-penetrant peptide blocking ZDHHC24–B7H3 interaction further boosts antitumor immunity and synergizes with PD-1 blockade.\"}]","Palmitic acid-triggered B7H3 palmitoylation promotes immune escape | PDF",1790125096,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54bc283e9c7a15377546fee68d9a10ec.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1f66a58cfb5f1955e62affd37b9fca1.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4e9dfe5f3e50735e20e635907be3d6a.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc12fbe7baf4928dbc57b873acbfcb55.webp",980,1301]